- Title
- Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate: preliminary aggregate results from three phase 1a randomized, double-blind, placebo controlled clinical trials
- Creators
- Kayvon Modjarrad - Walter Reed Army Institute of ResearchLeyi Lin - Walter Reed Army Institute of ResearchSarah L George - Saint Louis UniversityKathryn E Stephenson - Beth Israel Deaconess Medical CenterKenneth H Eckels - Walter Reed Army Institute of ResearchRafael A De La Barrera - Walter Reed Army Institute of ResearchRichard G Jarman - Walter Reed Army Institute of ResearchErica Sondergaard - Walter Reed Army Institute of ResearchJanice Tennant - Saint Louis UniversityJessica Ansel - Beth Israel Deaconess Medical CenterKristin Mills - Walter Reed Army Institute of ResearchMichael Koren - Walter Reed Army Institute of ResearchMerlin L Robb - Henry M. Jackson FoundationJill Barrett - EmmesJason Thompson - EmmesAlison E Kosel - EmmesPeter Dawson - EmmesAndrew Hale - University of Vermont Medical CenterC Sabrina Tan - Beth Israel Deaconess Medical CenterStephen Walsh - Beth Israel Deaconess Medical CenterKeith E Meyer - Saint Louis UniversityJames Brien - Saint Louis UniversityTrevor A Crowell - Henry M. Jackson FoundationAzra Blazevic - Saint Louis UniversityKarla Mosby - Saint Louis UniversityRafael A Larocca - Beth Israel Deaconess Medical CenterPeter Abbink - Beth Israel Deaconess Medical CenterMichael Boyd - Beth Israel Deaconess Medical CenterChristine A Bricault - Beth Israel Deaconess Medical CenterMichael Seaman - Beth Israel Deaconess Medical CenterAnne Basil - Henry M. Jackson FoundationMelissa Walsh - Henry M. Jackson FoundationVeronica Tonwe - Walter Reed Army Institute of ResearchDaniel F Hoft - St. Louis VA Medical CenterStephen J Thomas - Walter Reed Army Institute of ResearchDan H Barouch - Beth Israel Deaconess Medical CenterNelson L Michael - Walter Reed Army Institute of Research
- Publication Details
- The Lancet (British edition), Vol.391(10120), pp.563-571
- Identifiers
- 991006150221502656
- Academic Unit
- Infectious Disease
- Language
- English
- Resource Type
- Journal article
Journal article
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate: preliminary aggregate results from three phase 1a randomized, double-blind, placebo controlled clinical trials
The Lancet (British edition), Vol.391(10120), pp.563-571
12/05/2017
PMID: 29217375
Metrics
1 Record Views